Neurocognition in Pediatric Temporal Lobe Tumor-Related Epilepsy

Area of Science:

• Neurology
• Neuropsychology
• Pediatric Oncology

Background:

• Tumor-related epilepsy is a frequent neurological comorbidity in pediatric temporal lobe tumor (TLT) patients.
• It poses a significant risk for neurocognitive impairment (NCI).
• This area remains understudied, particularly in differentiating outcomes between tumor-related and nonneoplastic epilepsy.

Purpose of the Study:

• To compare neurocognitive impairment (NCI) rates in pediatric patients with temporal lobe tumors and epilepsy (TLT+) versus those with nonneoplastic temporal lobe epilepsy.
• To identify factors associated with NCI in these distinct pediatric epilepsy populations.
• To explore the need for separate prognostic models for cognitive outcomes.

Main Methods:

• Neuropsychological evaluations were administered to 41 youth (ages 6-20).
• Participants included 23 with TLT+ and 18 with nonneoplastic temporal lobe epilepsy.
• Statistical analyses compared NCI rates and associated factors between groups.

Main Results:

• Overall NCI rates were comparable between TLT+ and nonneoplastic epilepsy groups.
• Nonneoplastic epilepsy participants showed higher NCI on phonemic fluency tasks (p=.047).
• In TLT+ participants, younger age of seizure onset and more antiseizure medications correlated with NCI.

Conclusions:

• Pediatric populations with TLT+ and nonneoplastic epilepsy exhibit distinct cognitive profiles.
• Separate prognostic models for cognitive outcomes may be required for these groups.
• Further research is needed to refine understanding and management of NCI in pediatric epilepsy.